Bioventus to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 25, 2021
Bioventus Inc. (Nasdaq: BVS) announced that it will release its fourth quarter and fiscal year 2020 financial results on March 25, 2021, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Bioventus Inc. (Nasdaq: BVS) announced that it will release its fourth quarter and fiscal year 2020 financial results on March 25, 2021, after market close. Management will host a conference call at 5:00 p.m. ET on the same day to discuss the results and provide a business update, followed by a Q&A session. Interested participants can join via phone or through a live webcast available on the investor relations section of the company's website. The webcast will be archived for replay until March 25, 2022.
Details
News Market Reaction – BVS
The recorded move for BVS in the trading session of this news was +0.08%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
DURHAM, N.C., March 01, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that fourth quarter and fiscal year 2020 financial results will be released after the market closes on Thursday, March 25, 2021.
Management will host a conference call to discuss its financial results and provide a business update, with a question and answer session, at 5:00 p.m. Eastern Time on March 25, 2021. Those who would like to participate may dial 844-945-2085 (442-268-1266 for international callers) and provide access code 2158468. A live webcast of the call and any accompanying materials will also be provided on the investor relations section of the Company's website at https://ir.bioventus.com/.
The webcast will be archived on the Company’s website at https://ir.bioventus.com/ and available for replay until March 25, 2022.
About Bioventus
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for osteoarthritis, surgical and non-surgical bone healing. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com and follow the company on LinkedIn and Twitter. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.